Deals, Financing

VC OrbiMed closes the financing commitment with $735 million

Posted on 04 November 2013

Tags: , ,

OrbiMed announced the closing of its next venture capital financing with just over $735 million in commitments.

The financing includes approximately $36 million from the General Partner.

Investors in the fund include some of the largest endowments, foundations, sovereign wealth funds and financial institutions globally.

The new fund will invest in all stages and sectors of the healthcare industry, with a focus on biopharmaceutical, medical device, and diagnostics companies located in North America and Europe.

The new fund is expected to invest in approximately 30 portfolio companies in amounts generally ranging from $10 million to $50 million.

For further deal information visit Current Agreements (subscription required)



Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary

View: Current Partnering’s Financing Scorecard – view top life science financing deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply